Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Epidemiological Study on Community Acquired Pneumonia (CAPNETZ)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02139163
Recruitment Status : Recruiting
First Posted : May 15, 2014
Last Update Posted : July 31, 2020
Sponsor:
Information provided by (Responsible Party):
Hannover Medical School

Tracking Information
First Submitted Date January 24, 2014
First Posted Date May 15, 2014
Last Update Posted Date July 31, 2020
Study Start Date October 2002
Estimated Primary Completion Date January 2021   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: May 12, 2014)
  • diagnosis [ Time Frame: 2 weeks ]
    Assessment of diagnosis: Patients will be asked for example, about their diagnosis, comorbidities, specific risk factors and pneumonia symptoms.
  • therapy [ Time Frame: 2 weeks ]
    Assessment of therapy: Patients will be asked about their therapy due to pneumonia symptoms, previous therapy, medication History etc.
  • hospitalization [ Time Frame: 2 weeks ]
    Assessment of hospitalization: Patients will be asked about hospitalization, date, time and duration of hospitalization due to pneumonia symptoms.
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Epidemiological Study on Community Acquired Pneumonia
Official Title Epidemiological Study on Community Acquired Pneumonia
Brief Summary Long-term objectives of the basic research part are improvement of CAP-management with respect to therapy, diagnosis and prevention to contribute to a better care of patients with pneumonia.
Detailed Description Long-term objectives of the basic research part are improvement of CAP-management with respect to therapy, diagnosis and prevention to contribute to a better care of patients with pneumonia. The aim of the study CAPNETZ is to improve diagnosis, treatment and patient care.
Study Type Observational [Patient Registry]
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration 6 Months
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population patients with pneumonia
Condition Community Acquired Pneumonia
Intervention Other: Cohort Study
Study Groups/Cohorts patients with pneumonia
Intervention: Other: Cohort Study
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: May 12, 2014)
10150
Original Estimated Enrollment Same as current
Estimated Study Completion Date January 2022
Estimated Primary Completion Date January 2021   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • age ≥ 18
  • infiltrate on chest X-ray
  • further Inclusion criteria: cough or production of purulent sputum or pathologic lung auscultation (crackles) or fever

Exclusion Criteria:

  • hospital inpatient treatment within the last 28 days
  • Immune suppressed patients
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts
Contact: Tobias Welte, Prof. +49-511-532-5927 office@capnetz.de
Listed Location Countries Germany
Removed Location Countries  
 
Administrative Information
NCT Number NCT02139163
Other Study ID Numbers U1111-1147-8393
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Hannover Medical School
Study Sponsor Hannover Medical School
Collaborators Not Provided
Investigators
Study Chair: Tobias Welte, Prof. Dr. Hannover Medical School
PRS Account Hannover Medical School
Verification Date July 2020